Last10K.com

Advaxis, Inc. (ADXS) SEC Filing 8-K Material Event for the period ending Thursday, June 17, 2021

SEC Filings

ADXS Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ADXS Annual Reports

ADXS Quarterly Reports

ADXS Corporate News

ADXS Merger Prospectus

ADXS Registration of Securities

Advaxis, Inc.

HISTORY TOOLS
CIK: 1100397 Ticker: ADXS

View differences made from one to another to evaluate Advaxis, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advaxis, Inc..

Continue

Assess how Advaxis, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advaxis, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ADXS
CIK: 1100397
Form Type: 8-K Corporate News
Accession Number: 0001493152-21-014786
Submitted to the SEC: Mon Jun 21 2021 7:00:21 AM EST
Accepted by the SEC: Mon Jun 21 2021
Period: Thursday, June 17, 2021
Industry: Pharmaceutical Preparations
Events:
  1. Other Events
  2. Vote of Security Holders

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/adxs/0001493152-21-014786.htm